• Something wrong with this record ?

Aagenaes syndrome/lymphedema cholestasis syndrome 1 is caused by a founder variant in the 5'-untranslated region of UNC45A

R. Almaas, M. Atneosen-Åsegg, ME. Ytre-Arne, M. Melheim, HS. Sorte, D. Cízková, HM. Reims, A. Bezrouk, SP. Harrison, J. Strand, JU. Hermansen, SS. Andersen, KL. Eiklid, J. Mokrý, GJ. Sullivan, A. Stray-Pedersen

. 2023 ; 79 (4) : 945-954. [pub] 20230614

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND & AIMS: Lymphedema cholestasis syndrome 1 or Aagenaes syndrome is a condition characterized by neonatal cholestasis, lymphedema, and giant cell hepatitis. The genetic background of this autosomal recessive disease was unknown up to now. METHODS: A total of 26 patients with Aagenaes syndrome and 17 parents were investigated with whole-genome sequencing and/or Sanger sequencing. PCR and western blot analyses were used to assess levels of mRNA and protein, respectively. CRISPR/Cas9 was used to generate the variant in HEK293T cells. Light microscopy, transmission electron microscopy and immunohistochemistry for biliary transport proteins were performed in liver biopsies. RESULTS: One specific variant (c.-98G>T) in the 5'-untranslated region of Unc-45 myosin chaperone A (UNC45A) was identified in all tested patients with Aagenaes syndrome. Nineteen were homozygous for the c.-98G>T variant and seven were compound heterozygous for the variant in the 5'-untranslated region and an exonic loss-of-function variant in UNC45A. Patients with Aagenaes syndrome exhibited lower expression of UNC45A mRNA and protein than controls, and this was reproduced in a CRISPR/Cas9-created cell model. Liver biopsies from the neonatal period demonstrated cholestasis, paucity of bile ducts and pronounced formation of multinucleated giant cells. Immunohistochemistry revealed mislocalization of the hepatobiliary transport proteins BSEP (bile salt export pump) and MRP2 (multidrug resistance-associated protein 2). CONCLUSIONS: c.-98G>T in the 5'-untranslated region of UNC45A is the causative genetic variant in Aagenaes syndrome. IMPACT AND IMPLICATIONS: The genetic background of Aagenaes syndrome, a disease presenting with cholestasis and lymphedema in childhood, was unknown until now. A variant in the 5'-untranslated region of the Unc-45 myosin chaperone A (UNC45A) was identified in all tested patients with Aagenaes syndrome, providing evidence of the genetic background of the disease. Identification of the genetic background provides a tool for diagnosis of patients with Aagenaes syndrome before lymphedema is evident.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016151
003      
CZ-PrNML
005      
20231026110315.0
007      
ta
008      
231013s2023 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jhep.2023.05.037 $2 doi
035    __
$a (PubMed)37328071
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Almaas, Runar $u Department of Pediatric Research, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Paediatrics, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway; European Reference Network - Rare Liver. Electronic address: runar.almaas@ous-hf.no
245    10
$a Aagenaes syndrome/lymphedema cholestasis syndrome 1 is caused by a founder variant in the 5'-untranslated region of UNC45A / $c R. Almaas, M. Atneosen-Åsegg, ME. Ytre-Arne, M. Melheim, HS. Sorte, D. Cízková, HM. Reims, A. Bezrouk, SP. Harrison, J. Strand, JU. Hermansen, SS. Andersen, KL. Eiklid, J. Mokrý, GJ. Sullivan, A. Stray-Pedersen
520    9_
$a BACKGROUND & AIMS: Lymphedema cholestasis syndrome 1 or Aagenaes syndrome is a condition characterized by neonatal cholestasis, lymphedema, and giant cell hepatitis. The genetic background of this autosomal recessive disease was unknown up to now. METHODS: A total of 26 patients with Aagenaes syndrome and 17 parents were investigated with whole-genome sequencing and/or Sanger sequencing. PCR and western blot analyses were used to assess levels of mRNA and protein, respectively. CRISPR/Cas9 was used to generate the variant in HEK293T cells. Light microscopy, transmission electron microscopy and immunohistochemistry for biliary transport proteins were performed in liver biopsies. RESULTS: One specific variant (c.-98G>T) in the 5'-untranslated region of Unc-45 myosin chaperone A (UNC45A) was identified in all tested patients with Aagenaes syndrome. Nineteen were homozygous for the c.-98G>T variant and seven were compound heterozygous for the variant in the 5'-untranslated region and an exonic loss-of-function variant in UNC45A. Patients with Aagenaes syndrome exhibited lower expression of UNC45A mRNA and protein than controls, and this was reproduced in a CRISPR/Cas9-created cell model. Liver biopsies from the neonatal period demonstrated cholestasis, paucity of bile ducts and pronounced formation of multinucleated giant cells. Immunohistochemistry revealed mislocalization of the hepatobiliary transport proteins BSEP (bile salt export pump) and MRP2 (multidrug resistance-associated protein 2). CONCLUSIONS: c.-98G>T in the 5'-untranslated region of UNC45A is the causative genetic variant in Aagenaes syndrome. IMPACT AND IMPLICATIONS: The genetic background of Aagenaes syndrome, a disease presenting with cholestasis and lymphedema in childhood, was unknown until now. A variant in the 5'-untranslated region of the Unc-45 myosin chaperone A (UNC45A) was identified in all tested patients with Aagenaes syndrome, providing evidence of the genetic background of the disease. Identification of the genetic background provides a tool for diagnosis of patients with Aagenaes syndrome before lymphedema is evident.
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a 5' nepřekládaná oblast $x genetika $7 D020121
650    _2
$a transportní proteiny $x genetika $7 D002352
650    12
$a cholestáza $x genetika $7 D002779
650    _2
$a HEK293 buňky $7 D057809
650    12
$a intracelulární signální peptidy a proteiny $x genetika $7 D047908
650    12
$a lymfedém $x diagnóza $x genetika $x metabolismus $7 D008209
650    _2
$a myosiny $x genetika $x metabolismus $7 D009218
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Atneosen-Åsegg, Monica $u Institute of Clinical Medicine, University of Oslo, Oslo, Norway
700    1_
$a Ytre-Arne, Mari Eknes $u Norwegian National Unit for Newborn Screening, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
700    1_
$a Melheim, Maria $u Department of Pediatric Research, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway; European Reference Network - Rare Liver
700    1_
$a Sorte, Hanne Sørmo $u Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
700    1_
$a Cízková, Dana $u Department of Histology and Embryology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Reims, Henrik Mikael $u European Reference Network - Rare Liver; Department of Pathology, Oslo University Hospital, Oslo, Norway
700    1_
$a Bezrouk, Aleš $u Department of Medical Biophysics, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Harrison, Sean Philip $u Department of Pediatric Research, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway; European Reference Network - Rare Liver
700    1_
$a Strand, Janne $u Norwegian National Unit for Newborn Screening, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
700    1_
$a Hermansen, Johanne Uthus $u Department of Pediatric Research, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway
700    1_
$a Andersen, Sofie Strøm $u Department of Pediatric Research, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway
700    1_
$a Eiklid, Kristin Louise $u Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
700    1_
$a Mokrý, Jaroslav $u Department of Histology and Embryology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Sullivan, Gareth John $u Department of Pediatric Research, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; European Reference Network - Rare Liver
700    1_
$a Stray-Pedersen, Asbjørg $u European Reference Network - Rare Liver; Norwegian National Unit for Newborn Screening, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
773    0_
$w MED00010017 $t Journal of hepatology $x 1600-0641 $g Roč. 79, č. 4 (2023), s. 945-954
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37328071 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026110310 $b ABA008
999    __
$a ok $b bmc $g 1999962 $s 1202513
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 79 $c 4 $d 945-954 $e 20230614 $i 1600-0641 $m Journal of hepatology $n J Hepatol $x MED00010017
LZP    __
$a Pubmed-20231013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...